← Leaderboards
Kui Li
University Of Texas Medical Br Galveston
$4,512,519
Attributed
$5,061,580
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $507K · FY2007–23$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,061,580 · 7
By mechanism
R01$2,531,041 · 1
R21$2,230,622 · 5
R56$299,917 · 1
Top collaborators
- Lu Lu3 shared
- Malia B Potts2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Shinji Makino$11,956,927
- E Aubrey Thompson$2,793,172
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionViralPathway InteractionsComplexLeadLifeSignal TransductionPathogenResponseMediatingSignal PathwayInterferonsHepatitis C VirusCytokineVirus DiseasesGenesRna VirusesVirus ReplicationMolecularVirusDesignHepatitis CNf-Kappa BCells
Grant awards (22)
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2$192,500
R21 · FY2023 · AI · contact PI
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2$231,000
R21 · FY2022 · AI · contact PI
Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2$205,810
R21 · FY2022 · AI · contact PI
Molecular mechanisms governing the regulation of innate antiviral immunity by the SRMS kinase$207,187
R21 · FY2020 · AI · contact PI
Molecular mechanisms governing the regulation of innate antiviral immunity by the SRMS kinase$261,625
R21 · FY2019 · AI · contact PI
TRIMing Flavivirus Infection by a Host-encoded E3 Ligase$190,000
R21 · FY2019 · AI · contact PI
TRIMing Flavivirus Infection by a Host-encoded E3 Ligase$228,000
R21 · FY2018 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$337,500
R01 · FY2016 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$337,500
R01 · FY2015 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$300,000
R01 · FY2014 · AI · contact PI
Role of TRIM56 in Antiviral Innate Immunity$187,500
R21 · FY2014 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$282,000
R01 · FY2013 · AI · contact PI
Role of TRIM56 in Antiviral Innate Immunity$225,000
R21 · FY2013 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$299,917
R56 · FY2012 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$249,022
R01 · FY2011 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$251,538
R01 · FY2010 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$253,507
R01 · FY2009 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$128,837
R01 · FY2008 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$126,887
R01 · FY2008 · AI · contact PI
Role of TLR3 Signaling in Control of HCV$264,250
R01 · FY2007 · AI · contact PI
Impact of HCV NS3/4A Protease on Host Innate Immunity$151,000
R21 · FY2004 · DA
Impact of HCV NS3/4A Protease on Host Innate Immunity$151,000
R21 · FY2003 · DA